Search - tctmd.com

Displaying 101 - 120 of 128

Sort: Relevancy | Date

News Daily News

As the Number of US TAVR Centers Grows, Patient Outcomes Vary

Todd Neale

December 07, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Daily News

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

L.A. McKeown

August 03, 2015

News Daily News

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

L.A. McKeown

August 03, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

June 03, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Todd Neale

January 12, 2015

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

Advertisement

As the Number of US TAVR Centers Grows, Patient Outcomes Vary

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Statement on LAA Closure Highlights Key Issues for Growing Field

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Best Degree of Oversizing Varies by TAVR Device

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

Medtronic CoreValve® System Obtains Early FDA Approval

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content